Single award · contract
Advanced Research and Development of Rvsv-MARV Vaccine
Award ID: 75A50119C00022
A single federal award, with both ends of the trail linked.
$89M
Total award value
Award 75A50119C00022 is a contract from the Department of Health and Human Services, $89M obligated, FY2019 to FY2029, for Advanced Research and Development of Rvsv-MARV Vaccine. The work is performed in Massachusetts. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source
Description
Advanced Research and Development of Rvsv-MARV Vaccine.
Award details
Award typeContract
PIID75A50119C00022
Action date2019
Period120 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceMassachusetts →
CategoryNAICS 541714PSC AN13
Competed?Not recordedSource
Total (exact)$89,026,883
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.